NGVT
NGVT
NYSE · Chemicals

Ingevity Corp

$68.20
+0.14 (+0.21%)
As of Sep 20, 10:04 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.09B
Net Income
-155,507,675
Gross Margin
39.5%
Profit Margin
-14.3%
Rev Growth
-11.2%
D/E Ratio
40.69
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 39.5% 39.5% 54.7% 54.7%
Operating Margin -12.2% -11.0% 9.7% 8.4%
Profit Margin -14.3% -13.6% 8.3% 7.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.09B 1.22B 1.58B 1.41B
Gross Profit 429.54M 483.77M 864.01M 770.79M
Operating Income -132,239,868 -134,041,988 152.89M 118.22M
Net Income -155,507,675 -157,626,880 130.65M 101.13M
Gross Margin 39.5% 39.5% 54.7% 54.7%
Operating Margin -12.2% -11.0% 9.7% 8.4%
Profit Margin -14.3% -13.6% 8.3% 7.2%
Rev Growth -11.2% -11.2% +17.8% +22.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.14B 1.14B 220.13M 210.25M
Total Equity 28.06M 28.06M 1.03B 929.02M
D/E Ratio 40.69 40.69 0.21 0.23
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -102,277,342 -109,430,650 192.21M 179.91M
Free Cash Flow 123.30M 118.87M